Europe Branded Generics Market Forecast to 2028

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Branded Generics Market – By Therapeutic Application

1.3.2 Europe Branded Generics Market – By Distribution Channel

1.3.3 Europe Branded Generics Market – By Drug Class

1.3.4 Europe Branded Generics Market – By Formulation Type

1.3.5 Europe Branded Generics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Branded Generics Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Branded Generics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Popularity of Branded Generics

5.1.2 Rise in Government Initiatives for Promoting Branded Generics

5.2 Market Restraints

5.2.1 Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications

5.3 Market Opportunities

5.3.1 New Opportunities Owing to Product Differentiation

5.4 Future Trends

5.4.1 More Focus Upon Utility of Branded Generics by Healthcare Providers and Professionals

5.5 Impact Analysis

6. Branded Generics Market– Europe Analysis

6.1 Europe Branded Generics Market Revenue Forecast and Analysis

6.2 Europe Branded Generics Market, By Country - Forecast and Analysis

7. Europe Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application

7.1 Overview

7.2 Europe Branded Generics Market Revenue Share, By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)

7.3 Oncology

7.3.1 Overview

7.3.2 Oncology Market Revenue and Forecast to 2028 (US$ Billion)

7.4 Cardiovascular Diseases

7.4.1 Overview

7.4.2 Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.5 Diabetes

7.5.1 Overview

7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

7.6 Neurology

7.6.1 Overview

7.6.2 Neurology Market Revenue and Forecast to 2028 (US$ Billion)

7.7 Gastrointestinal Diseases

7.7.1 Overview

7.7.2 Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.8 Dermatology Diseases

7.8.1 Overview

7.8.2 Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.9 Analgesics and Anti-Inflammatory

7.9.1 Overview

7.9.2 Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

7.10 Others

7.10.1 Overview

7.10.2 Others Market Revenue and Forecast to 2028 (US$ Billion)

8. Europe Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel

8.1 Europe Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

8.2 Hospital Pharmacies

8.2.1 Overview

8.2.2 Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.3 Retail Pharmacies

8.3.1 Overview

8.3.2 Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.4 Online Pharmacies

8.4.1 Overview

8.4.2 Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.5 Drug Stores

8.5.1 Overview

8.5.2 Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9. Europe Branded Generics Market Analysis and Forecast to 2028 by Drug Class

9.1 Europe Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

9.2 Alkylating Agents

9.2.1 Overview

9.2.2 Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.3 Antimetabolites

9.3.1 Overview

9.3.2 Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.4 Hormones

9.4.1 Overview

9.4.2 Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.5 Anti-hypertensive

9.5.1 Overview

9.5.2 Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.6 Lipid Lowering Drugs

9.6.1 Overview

9.6.2 Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.7 Anti-Depressants

9.7.1 Overview

9.7.2 Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.8 Anti-psychotics

9.8.1 Overview

9.8.2 Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.9 Anti-epileptic

9.9.1 Overview

9.9.2 Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.10 Others

9.10.1 Overview

9.10.2 Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

10. Europe Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type

10.1 Overview

10.2 Europe Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

10.3 Oral

10.3.1 Overview

10.3.2 Oral Market Revenue and Forecast to 2028 (US$ Billion)

10.4 Parenteral

10.4.1 Overview

10.4.2 Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

10.5 Topical

10.5.1 Overview

10.5.2 Topical Market Revenue and Forecast to 2028 (US$ Billion)

10.6 Others

10.6.1 Overview

10.6.2 Others Market Revenue and Forecast to 2028 (US$ Billion)

11. Europe Branded Generics Market Revenue and Forecasts to 2028 Country Analysis

11.1 Overview

11.1.1 Europe: Branded Generics Market, by Country, 2022 & 2028 (%)

11.1.1.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.2 Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.3 Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.4 Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.5 Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.1 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.2 France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.3 France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.4 France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.5 France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.1 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.2 UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.3 UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.4 UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.5 UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.1 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.2 Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.3 Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.4 Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.4.5 Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.1 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.2 Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.3 Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.4 Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.5.5 Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.1 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.2 Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.3 Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.4 Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.6.5 Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

12. Branded Generics Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 MYLAN N.V.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GlaxoSmithKline plc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bausch Health Companies Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Lupin

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Sanofi

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 ASTRAZENECA PLC.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Dr. Reddy's Laboratories

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Par Pharmaceuticals, INC

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Sandoz International GMBH

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Aspen Holdings

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 Hetero

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms